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Background   Although nasal carriage of MRSA has been iden-
tified as one of the risk factors for surgical site infection (SSI) 
with MRSA, there have been no reports of this in the orthopedics 
field. 
Methods   This prospective observational cohort study included 
2,423 consecutive patients who were admitted to our department 
over  26  months  and  who  underwent  orthopedic  surgery.  We 
examined the relationship between pre-existing nasal MRSA and 
subsequent occurrence of SSI with MRSA. 
Results   63 patients (2.6%) had a positive nasal MRSA culture. 
15 patients (0.6%) developed SSI with MRSA. The occurrence of 
SSI with MRSA in nasal MRSA carriers was significantly higher 
than that in non-carriers (4 out of 63 (6.3%) vs. 11 out of 2,360 
(0.5%); p < 0.001) (adjusted OR: 11; 95% CI: 3–37; p = 0.001).
Interpretation      We  recommend  appropriate  treatment  of 
patients who are nasal carriers of MRSA before orthopedic sur-
gery. 

The first strains of methicillin-resistant Staphylococcus aureus 
(MRSA) were reported in the United Kingdom in 1961, only 
2 years after the introduction of methicillin (Barber 1961). 
Since then, similar strains have been isolated in other parts 
of the world (Barrett et al. 1968, Rountree and Beard 1968). 
Multidrug-resistant strains have been reported with increasing 
frequency worldwide, and we only have a few drugs that are 
effective in treating them (Lowy 1998, Moellering 1998). 
Infections caused by resistant strains (Kilgus et al. 2002), 
such as MRSA, can have serious consequences for patients 
undergoing orthopedic surgery, especially arthroplasties.
Nasal carriage of MRSA has been identified as one of the 
risk  factors  for  SSI  in  surgical  patients  (Mest  et  al.  1994, 
Kluytmans et al. 1997, Davis et al. 2004). It has been reported 
that nasal colonization with MRSA increases the risk of SSI 
with MRSA for patients treated in surgical intensive care units 
(Mest et al. 1994), patients admitted to hospital (Davis et al. 
2004), and patients who have undergone continuous ambula-
tory peritoneal dialysis (CAPD) (Lye et al. 1993). There have, 
however,  been  no  reports  on  the  relationship  between  car-
riership of MRSA in the nasal cavity and SSI with MRSA 
in orthopedics, especially in relation to joint prostheses. We 
examined the relationship between the existence of MRSA in 
the nasal cavity preoperatively and the occurrence of SSI with 
MRSA after orthopedic surgery.
Patients and methods
From April 1, 2003 to June 30, 2005, we prospectively investi-
gated all 3,294 consecutive patients who were admitted to the 
Department of Orthopedic Surgery, which has 140 beds (in a 
tertiary-care hospital). Of these, 532 patients who underwent 
non-surgical treatment, 16 patients who had active SSI with 
MRSA or other strains on admission, and 323 patients who 
were 17 years of age or younger were excluded. The study 
group  consisted  of  the  remaining  2,423  patients  who  had 
orthopedic surgery. Informed consent was obtained from these 
patients and nasal swabs were taken to check for the presence 
of MRSA. MRSA carriers were not decolonized before sur-
gery. All patients were followed up for at least 1 year after 
surgery in order to examine whether they had developed SSI 
with MRSA. This prospective observational cohort study was 
approved by the ethical committee of our institution.
Assessment of nasal MRSA
Both nares were sampled using a swab, at the outpatient clinic 
for scheduled surgery and at admission for emergency surgery. 
Swabs samples were cultured aerobically at 35°C for 24–48 
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Ltd., Kyoto, Japan) containing ceftizoxime (25 mg/L) with 
4% sodium chloride. Growth of Staphylococcus aureus was 
confirmed  by  the  Lecithovitellin  reaction.  Susceptibility  of 
isolates was determined with oxacillin by the dilution method 
using the Micro Scan system (Dade Behring Inc., West Sacra-
mento, CA) at a minimal inhibitory concentration of < 4 mg/L 
as breakpoint. 
Patient characteristics
Diagnosis of SSI was based on the criteria put forward by the 
Centers for Disease Control and Prevention (CDC) (Mangram 
et al. 1999), and it was classified into 3 groups: (1) superfi-
cial incisional surgical-site infection occurring within 30 days 
of surgery, (2) deep incisional surgical-site infection, and (3) 
organ/space surgical-site infections occurring within 30 days 
of surgery if no implant was left in place or within 1 year if the 
implant was in place and the infection appeared to be related 
to the surgery. Pathogens were examined in all the SSI cases. 
SSI with MRSA was assessed using the same culture method 
as used for nasal MRSA.
As risk factors for SSI with MRSA, the following factors 
were checked: sex, age at operation, history of diabetes mellitus 
and rheumatoid arthritis, the site of operation, use of a pros-
thesis, length of the surgical procedure, the existence of open 
fracture(s), Anaesthesiology Society of America (ASA) physi-
cal  status  classification  (Anonymous  1963),  and  body  mass 
index (BMI). Patients were considered to have diabetes mel-
litus or active rheumatoid arthritis if they had been treated with 
any anti-diabetic or anti-rheumatoid (including steroids and/or 
immunosuppressive) drugs. The site of operation was divided 
into three groups: upper extremity (from clavicle to finger), 
spine (from cervical spine to lumbar spine), or lower extremity 
(from pelvis and hip to toe). The use of a prosthesis for knee and 
hip, including total hip arthroplasty and femoral head prosthetic 
replacement, was defined as use of a prosthesis. The ASA clas-
sification involves 5 scores (from 1 to 5); the higher the score, 
the worse the general condition (Anonymous 1963).
Statistics
Patients admitted several times during the study period were 
included only once in the analysis. ASA classes 3 and 4 were 
combined because the number of patients with class 4 was 
small, and no patients were classified as class 5. Thus, ASA 
score  was  divided  into  3  groups.  Differences  between  the 
groups were assessed by Chi square test or Wilcoxon rank 
sum test. Fisher’s exact test was also used where appropri-
ate. Multiple logistic regression analysis was performed to 
estimate adjusted odds ratios (ORs) and their 95% confidence 
intervals (CIs). The test for trend was performed by including 
explanatory variables in the model that were coded by ordinal 
numbers with increasing categories of exposure. All statisti-
cal analyses were performed using SAS software version 9.1 
(SAS Institute, Inc., Cary, NC). Statistical significance was set 
at p < 0.05.
Results
2,423 patients (1,272 males and 1151 females) were studied. 
The average age at admission was 55 years (SD 19; range 18–
96). The average length of the surgical procedure was 117 min 
(SD 85; range 5–935). 1,059 patients were classified as ASA 
class 1, 1,079 patients as class 2, 280 patients as class 3, and 
5 patients as class 4. The average BMI on admission was 23 
(SD 3.9; range 15–36). The average follow-up period was 26 
(13–38) months. Of these patients, 63 (2.6%) had preopera-
tive nasal cultures that were positive for MRSA. Overall, 15 
patients (0.6%) developed SSI with MRSA postoperatively. 
The mean time of onset of SSI with MRSA was 1.1 months 
(range 4 days to 3 months). No other organisms were detected 
in these 15 patients. According to the criteria defined by CDC, 
6 patients had superficial incisional SSI, 1 patient had deep 
incisional SSI, and 8 patients had organ/space SSI. 1 patient 
had removal of a joint prosthesis, and 2 patients had limb 
amputation (Table 1). 3 patients with joint prostheses (1 femo-
ral head prosthesis and 2 total knee prostheses) had SSI with 
MRSA. The latter 2 patients who had total knee replacement 
could retain their prostheses by debridement and antibiotic 
treatment. For the 1 patient who had replacement of a femo-
ral head prosthesis, debridement and antibiotic treatment were 
not effective and removal of prosthesis was required.
Patients  with  preoperative  nasal  cultures  that  were  posi-
tive for MRSA had a higher occurrence of SSI with MRSA 
(6.3%)  than  patients  who  were  negative  for  nasal  MRSA 
preoperatively  (0.5%),  by  crude  rate  analysis  (p  <  0.001) 
(Table 2). Patients with nasal cultures that were positive for 
MRSA  preoperatively  were  statistically  significantly  older 
than patients who were negative for MRSA in nasal cultures, 
both in the total group (median age: 69 vs. 59, p = 0.001) 
and in the SSI negative group (median age: 69 vs. 59, p = 
0.001). However, in the SSI-positive group, the difference in 
age between patients who were positive or negative for MRSA 
in nasal swabs preoperatively was not statistically significant 
(median age: 69 vs. 59, p = 0.5). There was no significant 
association  between  gender  and  preoperative  nasal  culture 
status in any of the 3 groups.
Possible associations between SSI with MRSA and periop-
erative factors (sex, age, history of diabetes mellitus, history 
of rheumatoid arthritis, the site of operation, use of a pros-
thesis, length of the surgical procedure, the existence of open 
fracture(s), ASA class, and BMI), as well as preoperative cul-
ture of nasal MRSA, were examined. By crude rate analysis, 
sex, age, history of diabetes mellitus and rheumatoid arthritis, 
the site of operation, use of a prosthesis, length of the surgi-
cal procedure, existence of open fracture(s), an ASA class of 
1 or 2, and BMI were not statistically significant factors for 
SSI with MRSA. Nasal cultures that were positive for MRSA 
preoperatively and an ASA class of 3 or 4 were associated 
with SSI with MRSA by crude rate analysis (OR: 15; 95% 
CI: 4.5–47; p < 0.001; and OR: 6, 95% CI: 1.5–27; p = 0.01, 488  Acta Orthopaedica 2009; 80 (4): 486–490
respectively). Multivariate logistic regression analysis showed 
that preoperative culture of nasal MRSA was only statistically 
significantly associated with SSI with MRSA even after con-
trolling for perioperative factors (adjusted OR: 11; 95% CI: 
3–37; p < 0.001). Thus, positive culture of nasal MRSA inde-
pendently increased the risk of SSI with MRSA by 11 times 
(Table 2).
Concerning the 4 patients who had positive results of cul-
ture of nasal MRSA preoperatively and SSI with MRSA sub-
sequently, the susceptibility patterns of the MRSA isolates 
obtained from the nasal cavity and from the surgical site were 
the same.
Discussion
We found that the adjusted OR of nasal MRSA for SSI with 
MRSA after orthopedic surgery was 11 after controlling for the 
effects of potential confounders. Mest et al. (1994) reported a 
prospective study on patients who were treated in the surgi-
cal intensive care unit from all surgical wards. They screened 
all patients preoperatively for nasal carriage of MRSA and 
found that 4% of patients had MRSA-positive nasal cultures. 
26% of these MRSA carriers developed MRSA infections, as 
compared to 1.3% of those who were not carriers. Davis et 
al. (2004) reported a prospective study on subsequent MRSA 
Table 1. Demographic and clinical data of 16 patients with MRSA surgical site infection
No.  Culture of   Site of a  Sex b  Age  Usage of   Infection onset after   Criteria of   Number of   Outcome
  nasal MRSA  operation      prosthesis  the operation c  SSI d  additional operations
  1  +  L  M  56  –  4W  S  1  Resolved
  2  +  S  F  75  –  3M  O/S  1  Resolved
  3  +  S  F  69  –  2W  O/S  2  Resolved
  4  +  L  F  68  –  4W  D  2  Amputated
  5  –  U  M  58  –  4W  S  1  Resolved
  6  –  L  M  70  +  4W  O/S  1  Resolved
  7  –  U  F  54  –  2W  S  2  Resolved
  8  –  L  F  60  +  1M  S  1  Resolved
  9  –  L  M  74  –  1M  S  1  Resolved
  10  –  L  M  21  –  3W  S  1  Resolved
  11  –  U  M  58  –  4D  O/S  1  Resolved
  12  –  L  M  44  –  3M  O/S  3  Resolved
  13  –  L  M  50  –  3W  O/S  2  Amputated
  14  –  L  F  81  +  2W  O/S  4  Removed
  15  –  L  M  70  –  4W  O/S  1  Resolved
a U; upper extremity, S; spine, L; lower extremity
b M; male, F; female
c D; day, W; week, M; month
d S; superficial, D; deep, O/S; organ/space
Table 2. Crude and adjusted ORs and 95%CIs for surgical site infection with MRSA using logistic regression model
Variable  Surgical site infection  Crude  Adjusted a
    
  n / N  (%)  OR (95% CI)  p-value  OR (95% CI)  p-value
Culture of nasal MRSA  –  11 / 2360  (0.5)  1    1 
    +    4 / 63  (6.3)  15  (4.5–47)  <0.001  11  (3.0–37)  <0.001
Sex  M    9 / 1272  (0.7)  1    1 
    F    6 / 1151  (0.5)  1.4 (0.5–3.8)  0.6  1.7 (0.5–5.4)  0.4
Age per 10-year increase        1.2 (0.9–1.6)  0.3  1.1 (0.7–1.5)  0.8
Length of surgical procedure 
  per 10-minute increase        1.0 (1.0–1.1)  0.1  1.0 (1.0–1.1)  0.2
ASA class  1    3 / 1059  (0.3)  1    1 
    2    7 / 1079  (0.7)  2.3 (0.6–8.9)  0.2  2.2 (0.5–10)  0.3
    3, 4    5 / 285  (1.8)  6.3 (1.5–27)  0.01  4.2 (0.6–27)  0.1
  Trend        p=0.04    p=0.1
BMI        1.0 (0.9–1.1)  0.7  1.0 (0.9–1.1)  0.8
a model included usage of prosthesis, site of infection, open fracture, history of diabetes mellitus, and history of rheu-
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infections in patients admitted to 5 units in their hospital. 3% 
of the patients were MRSA carriers. The rate of subsequent 
MRSA infections in nasal carriers of MRSA was 10 times as 
much as that in non-carriers. Lye et al. (1993) reported a pro-
spective study on MRSA infection in patients entering into the 
continuous ambulatory peritoneal dialysis (CAPD) program. 
17% of these patients were nasal carriers of MRSA. Nasal car-
riage was associated with a statistically significant increase in 
the rate of postoperative MRSA infection, such as peritonitis, 
catheter losses, and dropouts of CAPD (Lye et al. 1993). Our 
findings in orthopedic surgery were similar to these previous 
reports regarding the relationship between nasal carriership of 
MRSA and MRSA infection. However, the rates of nasal car-
riership of MRSA and MRSA infections were lower in our 
study. The difference may have been due to differences in the 
condition of patients, and differences in procedures.
The length of the surgical procedure, history of diabetes 
mellitus and rheumatoid arthritis, ASA class, and BMI have 
been reported to be risk factors for SSI caused by organisms 
other than MRSA in general surgery, orthopedic surgery, car-
diovascular surgery, and neurosurgery (Gil-Egea et al. 1987, 
Nagachinta et al. 1987, Wymenga et al. 1992, Pons et al. 1993, 
Slaughter et al. 1993, He et al. 1994, Barber et al. 1995, Ziv et 
al. 1996, Flynn et al. 2000, Syahrizal et al. 2001, Dindo et al. 
2003). However, there have been no reports on the relationship 
between such factors and SSI with MRSA. Apart from nasal 
MRSA, we thus used these as confounding factors in the mul-
tivariate logistic regression analysis. ASA class 3 and 4 was 
significantly associated with SSI with MRSA in crude analy-
sis. However, it was not significant in the adjusted analysis. 
This may have been because number of patients with higher 
ASA scores was small in this study.
In some reports, nasal mupirocin ointment was found to 
reduce the risk of S. aureus infection (Reagan et al. 1991, 
Kluytmans  et  al.  1995,  1996,  Gernaat-van  der  Sluis  et  al. 
1998), but this was not found to be the case in other reports 
(Kalmeijer et al. 2002, Perl et al. 2002). Recently, combina-
tion therapy with nasal mupirocin ointment and washing with 
disinfectants was reported to reduce MRSA infection after 
surgery (Wilcox et al. 2003, Simor et al. 2007).
One weakness of our study was that although we found 
exactly the same susceptibility patterns for MRSA isolates 
obtained from the nasal cavity and for those in surgical-site 
infections, we did not perform phage typing. Phage typing 
could be used in future studies to show whether the SSI is 
caused by the same strain of MRSA as that cultured from the 
nasal cavity.
We believe that our findings are of clinical importance. We 
recommend preoperative nasal culture for MRSA and, if pos-
sible, appropriate treatment for nasal carriers of MRSA.
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